Filing Flows › AstraZeneca (AZN) › Who owns the stock
Who owns AstraZeneca (AZN) stock
0 funds reported AstraZeneca (AZN) shares in their latest 13F filings. Members of Congress and other officials disclosed 6 trades (5 buys, 1 sales).
Trades by Congress and other officials
| Date | Who | Trade | Amount |
|---|---|---|---|
| 2026-03-31 | Alan Armstrong | purchase | $1K–$15K |
| 2026-03-30 | Alan Armstrong | purchase | $15K–$50K |
| 2025-12-18 | Gilbert Cisneros | purchase | $1K–$15K |
| 2025-12-08 | Julia Letlow | purchase | $1K–$15K |
| 2025-11-19 | Gilbert Cisneros | purchase | $1K–$15K |
| 2025-10-31 | Lisa McClain | sale | $1K–$15K |
AstraZeneca's latest quarter
AstraZeneca, Q2 2026: revenue $30.7B (+9% year over year), operating margin 24.2%, net earnings $5.6B. The chart follows the revenue to costs, profit and cash.
Questions
Has Congress traded AZN stock?
Officials disclosed 6 trades on file: 5 buys and 1 sales. The latest: Alan Armstrong, purchase on 2026-03-31.
What is the short interest in AZN?
3,284,132 shares were sold short at the 2026-10-15 settlement, 25.41% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.